Challenges in evaluating bioequivalence of dermatological drug products.
Shah
V P
VP
Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Md., USA.
D000818:Animals; D002986:Clinical Trials as Topic; D003879:Dermatologic Agents / Q000493:pharmacokinetics* / Q000494:pharmacology; D016568:Drugs, Generic / Q000493:pharmacokinetics; D005069:Evaluation Studies as Topic; D006801:Humans; D066298:In Vitro Techniques; D012867:Skin / Q000378:metabolism; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration
D003879:Dermatologic Agents; D016568:Drugs, Generic